|
US6984754B1
(en)
|
1998-03-26 |
2006-01-10 |
University Of Saskatchewan Technologies Inc. |
Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
|
|
WO1999048858A2
(en)
*
|
1998-03-26 |
1999-09-30 |
University Of Saskatchewan Technologies Inc. |
Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
|
|
AU765603C
(en)
|
1998-04-14 |
2004-08-05 |
General Hospital Corporation, The |
Methods for treating neuropsychiatric disorders
|
|
TW555757B
(en)
|
1998-07-31 |
2003-10-01 |
Akzo Nobel Nv |
Aminomethylcarboxylic acid derivatives
|
|
DE19840611A1
(de)
*
|
1998-09-05 |
2000-03-09 |
Klaus Wanner |
GABA-uptake-Inhibitoren mit Pyrrolidinstruktur
|
|
WO2001002363A2
(en)
|
1999-07-06 |
2001-01-11 |
Vertex Pharmaceuticals Incorporated |
N-substituted glycine derivatives
|
|
TWI243173B
(en)
|
1999-11-17 |
2005-11-11 |
Akzo Nobel Nv |
Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
|
|
DOP2001000189A
(es)
|
2000-06-30 |
2002-03-30 |
Pfizer Prod Inc |
Benzofenonas y sulfonas como inhibidores de la captación de glicina
|
|
JP2004508312A
(ja)
|
2000-09-08 |
2004-03-18 |
グリアテック インコーポレイテッド |
置換ヒドラジン誘導体
|
|
US20020082283A1
(en)
|
2000-09-14 |
2002-06-27 |
Gliatech, Inc. |
Nitrogen-containing compounds and their use as glycine transport inhibitors
|
|
AR032653A1
(es)
|
2001-02-09 |
2003-11-19 |
Telik Inc |
Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
|
|
US6667336B2
(en)
*
|
2001-02-16 |
2003-12-23 |
Nps Allelix Corp. |
GlyT-1 inhibitors
|
|
US6566550B2
(en)
|
2001-06-21 |
2003-05-20 |
Pfizer Inc |
Substituted aromatic ethers as inhibitors of glycine transport
|
|
ATE305917T1
(de)
|
2001-08-16 |
2005-10-15 |
Pfizer Prod Inc |
Difluormethylen aromatische ether und ihre verwendung als inhibitoren des glycin-typ-1- transporters
|
|
US7189757B2
(en)
|
2001-10-16 |
2007-03-13 |
Hypnion, Inc. |
Treatment of sleep disorders using CNS target modulators
|
|
US20050009730A1
(en)
|
2001-10-16 |
2005-01-13 |
Dale Edgar |
Treatment of cns disorders using cns target modulators
|
|
US7355042B2
(en)
|
2001-10-16 |
2008-04-08 |
Hypnion, Inc. |
Treatment of CNS disorders using CNS target modulators
|
|
GB0219153D0
(en)
*
|
2002-08-16 |
2002-09-25 |
Pfizer Ltd |
Substituted glycine derivatives for use as medicaments
|
|
EP1587781A1
(en)
|
2002-11-05 |
2005-10-26 |
Eli Lilly And Company |
3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
|
|
JP2006524642A
(ja)
*
|
2003-04-30 |
2006-11-02 |
ハー・ルンドベック・アクチエゼルスカベット |
芳香族オキシフェニルおよび芳香族スルファニルフェニル誘導体
|
|
CA2536275A1
(en)
*
|
2003-08-21 |
2005-03-03 |
H. Lundbeck A/S |
The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression
|
|
US20050080100A1
(en)
*
|
2003-10-09 |
2005-04-14 |
Pfizer Inc |
Pyridylamino compounds and methods of use thereof
|
|
EA009903B1
(ru)
*
|
2003-10-14 |
2008-04-28 |
Пфайзер Продактс Инк. |
Бициклические [3.1.0] производные в качестве ингибиторов переносчиков глицина
|
|
JP2007528879A
(ja)
*
|
2004-03-12 |
2007-10-18 |
ハー・ルンドベック・アクチエゼルスカベット |
フェニルインダン誘導体
|
|
WO2005100301A1
(en)
*
|
2004-03-31 |
2005-10-27 |
Eli Lilly And Company |
2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
|
|
KR20070084574A
(ko)
|
2004-12-01 |
2007-08-24 |
칼립시스, 인코포레이티드 |
유도가능 산화질소 신타제 이량체화 억제제
|
|
UA95788C2
(en)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Fused pyrrole derivatives
|
|
SG172685A1
(en)
|
2006-06-28 |
2011-07-28 |
Amgen Inc |
Glycine transporter-1 inhibitors
|
|
EP2271625B1
(en)
|
2008-04-01 |
2012-09-12 |
Abbott GmbH & Co. KG |
Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
|
|
CN101613347B
(zh)
*
|
2008-06-23 |
2012-07-04 |
中国人民解放军军事医学科学院毒物药物研究所 |
胺类化合物及其医药用途
|
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
MX2014001457A
(es)
|
2011-08-05 |
2014-08-21 |
Abbvie Deutschland |
Derivados de aminocromano, de aminotiocromano y de amino-1,2,3,4-tetrahidroquinolina composiciones farmaceuticas que los contienen, y su uso en terapia.
|
|
US9187439B2
(en)
|
2011-09-21 |
2015-11-17 |
Inception Orion, Inc. |
Tricyclic compounds useful as neurogenic and neuroprotective agents
|
|
WO2013072520A1
(en)
|
2011-11-18 |
2013-05-23 |
AbbVie Deutschland GmbH & Co. KG |
N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
JP2016533375A
(ja)
|
2013-10-17 |
2016-10-27 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
アミノテトラリン誘導体およびアミノインダン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用
|
|
CA2924689A1
(en)
|
2013-10-17 |
2015-04-23 |
AbbVie Deutschland GmbH & Co. KG |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
CN104098479B
(zh)
*
|
2014-07-28 |
2016-02-10 |
昆明学院 |
含芳环的胺类化合物及其制备方法和应用
|
|
US20200123115A1
(en)
*
|
2017-06-26 |
2020-04-23 |
Esteve Pharmaceuticals, S.A. |
Compounds having multimodal activity against pain
|
|
WO2022187206A1
(en)
*
|
2021-03-01 |
2022-09-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Dual-target mu opioid and dopamine d3 receptors ligands; preparation and use thereof
|
|
US11596612B1
(en)
|
2022-03-08 |
2023-03-07 |
PTC Innovations, LLC |
Topical anesthetics
|